Vanguard Global Advisers’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.2K Hold
16,010
﹤0.01% 3080
2026
Q1
$38.7K Buy
+16,010
New +$43.6K ﹤0.01% 3121

Other funds holding GNLX

Vanguard Global Advisers's GNLX Position: Q2 2026 in Review

Vanguard Global Advisers held its Genelux (GNLX) position steady in Q2 2026 at 16,010 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3080.

Vanguard Global Advisers first reported a position in GNLX in Q1 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Vanguard Global Advisers held 16,010 shares of Genelux worth $48.2K as of Q2 2026.
  • Vanguard Global Advisers left its Genelux share count unchanged in Q2 2026.
  • Genelux made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3080 holding.
  • Vanguard Global Advisers first reported a position in Genelux in Q1 2026 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.